Statera Biopharma Inc. Soared
Statera Biopharma Inc. (STAB:NASDAQ) soared at $0.21, representing a gain of 35.2%. On Mon, Oct 17, 2022, STAB:NASDAQ hit a New 2-Week Intraday High of $0.23. The stock appeared on our News Catalysts scanner on Mon, Oct 17, 2022 at 04:14 PM in the 'BIOTECH' category. From Tue, Oct 04, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Thu, Oct 06, 2022 at $0.3 with a volume of 84M+.
About Statera Biopharma Inc. (STAB:NASDAQ)
Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.
Top 10 Gainers:
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 163.82%
- Inpixon (INPX:NASDAQ), 90.59%
- FedNat Holding Company (FNHC:NASDAQ), 60.35%
- Oblong Inc. (OBLG:NASDAQ), 54.38%
- Archaea Energy Inc. Class A (LFG:NYSE), 54.15%
- Babylon Holdings Limited Class A (BBLN:NYSE), 43.73%
- OPAL Fuels Inc. (OPAL:NASDAQ), 40.92%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 39.13%
- Statera Biopharma Inc. (STAB:NASDAQ), 35.22%
- Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ), 32.04%